Regulus Therapeutics Inc. 4
4 · Regulus Therapeutics Inc. · Filed May 8, 2017
Insider Transaction Report
Form 4
WRIGHT TIMOTHY MICHAEL
Chief R & D Officer
Transactions
- Award
Stock Option (Right to Buy)
2017-05-04+350,000→ 350,000 totalExercise: $1.70Exp: 2027-05-03→ Common Stock (350,000 underlying)
Footnotes (1)
- [F1]25% of the shares vest on May 4, 2018 and the remainder of the shares vest in equal installments on a monthly basis thereafter, such that the option is fully vested on May 4, 2021.